FY26 B1 mckesson B12614013F invega DEC 25
Ended Awarded Last action
- Contract number
- 15B41426F00000039
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6
- Awarding agency
-
Medical Center for Federal Prisoners Springfield
Correctional Facilities, Department of Justice
- Obligated
- $241,988
Award facts
- Contract value 100% obligated
- $241,988.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,012 | |
| Original award | $245,000 |
About this award
McKesson Corporation, a major pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a delivery order valued at $241,988.44 by the Medical Center for Federal Prisoners Springfield, a civilian facility under the Bureau of Prisons. The award, issued on December 1, 2025, with a completion date of December 31, 2025, procures INVEGA (paliperidone), a prescription antipsychotic medication, under a firm fixed-price delivery order arrangement. This award represents one of McKesson's numerous delivery orders supporting pharmaceutical supply to federal correctional facilities nationwide. The contract utilizes no small business set-aside designation, consistent with McKesson's established competitive standing as a large business prime contractor in the federal healthcare marketplace.
This delivery order falls within McKesson's broader federal contract portfolio with the Bureau of Prisons, which spans multiple correctional facilities including Federal Correctional Institutions, United States Penitentiaries, and Federal Medical Centers. The company serves as a critical pharmaceutical supplier to the federal correctional healthcare system, delivering both controlled and non-controlled medications essential to institutional medical operations. McKesson's extensive engagement with Bureau of Prisons facilities and other federal agencies, including the Department of Homeland Security and Indian Health Service, demonstrates its established role as a primary vendor for federal pharmaceutical and medical supply chain management.
Quick answers
Who was awarded contract 15B41426F00000039?
15B41426F00000039 was awarded to Mckesson Corporation by Medical Center for Federal Prisoners Springfield (Correctional Facilities) on December 1, 2025.
How much is contract 15B41426F00000039 worth?
The government has obligated $241,988 on 15B41426F00000039.
Is contract 15B41426F00000039 an order under another contract?
Yes. 15B41426F00000039 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B41426F00000039 competed?
The extent of competition for 15B41426F00000039 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award